Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
NCT ID:
NCT02801812
Eligibility Criteria:
Inclusion Criteria:
* At time of enrollment all subjects must be 18 years or older and give written consent.
* Patients with SLE must fulfill the 2012 SLICC classification criteria.
* SLE onset must be over 16 years of age.
* Patients with SLE and secondary anti-phospholipid syndrome will be also enrolled.
* Healthy controls will be selected according to the definition proposed in the protocol
Exclusion Criteria:
* Subject refuses to sign and/or he/she is not able to understand the patient informed consent.
* Subjects with periungual traumatic lesions that may create artifacts (i.e. recent manicure, onychophagia, or gardening).
* SLE overlapping with other rheumatic diseases such as Systemic Sclerosis, Rheumatoid Arthritis, Mixed Connective Tissue Disease, Sjögren's Syndrome, Dermatomyositis, Polymyositis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02801812
Study Brief:
Protocol Section:
NCT02801812